Physician profile
Christopher R Brown
NPI 1467567735
$2,301,508.04
in general payments reported to CMS, 2019-2025
15 companies · $131K in 2025
The $131K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.1M · 2020: $524K · 2021: $143K · 2022: $196K · 2023: $216K · 2024: $41K · 2025: $131K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $166K · Royalty Or License: $162K · Travel and Lodging: $46K · Food and Beverage: $7,832 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $165,687.50 |
| Royalty Or License | $161,595.55 |
| Travel and Lodging | $45,784.60 |
| Food and Beverage | $7,831.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,823.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,883,718.47 | 2019-2023 | Precept, Vuepoint |
| Alphatec Spine, INC | $403,435.46 | 2019-2025 | Other - Miscellaneous, Solus Alif, Amp |
| Sanara Medtech INC. | $10,962.39 | 2022-2024 | Celleraterx |
| Globus Medical, INC. | $2,004.86 | 2019-2022 | |
| Mml US, INC. | $350.22 | 2021-2023 | Reactiv8 |
| Centinel Spine, LLC | $168.72 | 2023 | Prodisc L |
| Zimmer Biomet Holdings, INC. | $160.82 | 2022 | |
| Providence Medical Technology, INC. | $120.82 | 2019 | |
| Medtronic, INC. | $113.57 | 2023 | |
| Bioventus LLC | $112.02 | 2024-2025 | |
| Si-Bone, INC. | $104.72 | 2019 | |
| Abiomed | $99.36 | 2025 | |
| Cerapedics INC. | $56.93 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Trackx Technology, INC. | $53.60 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $46.08 | 2024 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.